Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?: Commentary

Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events? Commentary

Andre M Dewolf, Michael Messod Abecassis^*

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	422-423
Number of pages	2
Journal	Nature Clinical Practice Gastroenterology and Hepatology
Volume	4
Issue number	8
DOIs	https://doi.org/10.1038/ncpgasthep0869
State	Published - Aug 1 2007

@article{fc1899f50b1c4b86bbe0046341047a8f,

title = "Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?: Commentary",

author = "Dewolf, {Andre M} and Abecassis, {Michael Messod}",

year = "2007",

month = aug,

day = "1",

doi = "10.1038/ncpgasthep0869",

language = "English (US)",

volume = "4",

pages = "422--423",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?

T2 - Commentary

AU - Dewolf, Andre M

AU - Abecassis, Michael Messod

PY - 2007/8/1

Y1 - 2007/8/1

UR - http://www.scopus.com/inward/record.url?scp=34547686040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547686040&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0869

DO - 10.1038/ncpgasthep0869

M3 - Short survey

C2 - 17579588

AN - SCOPUS:34547686040

VL - 4

SP - 422

EP - 423

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 8

ER -